<SEC-DOCUMENT>0001185185-23-000448.txt : 20230508
<SEC-HEADER>0001185185-23-000448.hdr.sgml : 20230508
<ACCEPTANCE-DATETIME>20230505181937
ACCESSION NUMBER:		0001185185-23-000448
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		15
CONFORMED PERIOD OF REPORT:	20230505
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20230508
DATE AS OF CHANGE:		20230505

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			IGC Pharma, Inc.
		CENTRAL INDEX KEY:			0001326205
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				202760393
		STATE OF INCORPORATION:			MD
		FISCAL YEAR END:			0331

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-32830
		FILM NUMBER:		23895366

	BUSINESS ADDRESS:	
		STREET 1:		10224 FALLS ROAD
		CITY:			POTOMAC
		STATE:			MD
		ZIP:			20854
		BUSINESS PHONE:		301-983-0998

	MAIL ADDRESS:	
		STREET 1:		10224 FALLS ROAD
		CITY:			POTOMAC
		STATE:			MD
		ZIP:			20854

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	India Globalization Capital, Inc.
		DATE OF NAME CHANGE:	20050505
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>igcpharma20230505_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<XBRL>
<?xml version="1.0" encoding="ASCII"?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Fri May 05 21:45:25 UTC 2023 -->
<html xmlns:igc="http://www.igcinc.us/20230505" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:compsci="http://compsciresources.com" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:us-types="http://fasb.org/us-types/2023" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns="http://www.w3.org/1999/xhtml"><head>
	<title>igcpharma20230505_8k.htm</title>

	<!-- Generated by ThunderDome Portal - 5/5/2023 9:15:33 PM -->

<meta content="text/html" http-equiv="Content-Type" />
</head>
<body><div style="font-size: 10pt; font-family: &#34;Times New Roman&#34;; padding: 0in 0.1in; cursor: auto;"><div>
</div><hr style="height: 3px; color: #000000; background-color: #000000; width: 100%; border: none; margin: 3pt 0"/><div>
</div><hr style="height: 1px; color: #000000; background-color: #000000; width: 100%; border: none; margin: 0 0 3pt 0"/><div>
</div><p style="font-family: &#34;Times New Roman&#34;; font-size: 16pt; font-variant: normal; text-align: center; margin: 0pt;"><b>UNITED STATES</b></p><div>

</div><p style="font-family: &#34;Times New Roman&#34;; font-size: 16pt; font-variant: normal; text-align: center; margin: 0pt;"><b>SECURITIES AND EXCHANGE COMMISSION</b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Washington, D.C. 20549</b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><hr class="hr-custom" style="text-align: center;height: 1px; color: #000000; background-color: #000000; width: 10%; border: none; margin: 0pt auto 0pt auto;"/><div>
</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">&#160;</p><div>

</div><p style="font-family: &#34;Times New Roman&#34;; font-size: 16pt; font-variant: normal; text-align: center; margin: 0pt;"><b>FORM <ix:nonNumeric contextRef="c0" name="dei:DocumentType">8-K</ix:nonNumeric></b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">&#160;</p><div>

</div><hr class="hr-custom" style="text-align: center;height: 1px; color: #000000; background-color: #000000; width: 10%; border: none; margin: 0pt auto 0pt auto;"/><div>
</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>CURRENT REPORT</b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934</b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Date of Report (Date of earliest event reported): <ix:nonNumeric contextRef="c0" format="ixt:date-monthname-day-year-en" name="dei:DocumentPeriodEndDate"><b><span style="text-decoration:underline">May 5, 2023</span></b></ix:nonNumeric></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><img alt="igc-logo1.jpg" src="igc-logo1.jpg"/></p><div>

</div><p style="font-family:Times New Roman;font-size:18pt;font-variant:normal;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="c0" name="dei:EntityRegistrantName"><b><span style="text-decoration:underline">IGC PHARMA, INC.</span></b></ix:nonNumeric></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">(Exact name of registrant as specified in charter)</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">	<tr>	<td style="vertical-align:top;width:3.2%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="c0" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode"><b><span style="text-decoration:underline">Maryland</span></b></ix:nonNumeric></p>	</td>	<td style="vertical-align:top;width:3.3%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="c0" name="dei:EntityFileNumber"><b><span style="text-decoration:underline">001-32830</span></b></ix:nonNumeric></p>	</td>	<td style="vertical-align:top;width:3.2%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="c0" name="dei:EntityTaxIdentificationNumber"><b><span style="text-decoration:underline">20-2760393</span></b></ix:nonNumeric></p>	</td>	</tr>	<tr>	<td style="vertical-align:top;width:3.2%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">(State or other jurisdiction of incorporation)</p>	</td>	<td style="vertical-align:top;width:3.3%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">(Commission File Number)</p>	</td>	<td style="vertical-align:top;width:3.2%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">(I.R.S. Employer Identification No.)</p>	</td>	</tr>
</table><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><span style="text-decoration:underline"><ix:nonNumeric contextRef="c0" name="dei:EntityAddressAddressLine1">10024 Falls Road</ix:nonNumeric>, <ix:nonNumeric contextRef="c0" name="dei:EntityAddressCityOrTown">Potomac</ix:nonNumeric>, <ix:nonNumeric contextRef="c0" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince">Maryland</ix:nonNumeric> <ix:nonNumeric contextRef="c0" name="dei:EntityAddressPostalZipCode">20859</ix:nonNumeric></span></b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">(Address of principal executive offices) (Zip Code)</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><span style="text-decoration:underline"><ix:nonNumeric contextRef="c0" name="dei:CityAreaCode">(301)</ix:nonNumeric> <ix:nonNumeric contextRef="c0" name="dei:LocalPhoneNumber">983-0998</ix:nonNumeric></span></b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">(Registrant&#8217;s telephone number, including area code)</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 8pt;"><b><ix:nonNumeric contextRef="c0" name="dei:EntityInformationFormerLegalOrRegisteredName">India Globalization Capital, Inc.</ix:nonNumeric><br/>
<span style="text-decoration:underline">4336 Montgomery Ave., Bethesda MD 20814</span></b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 8pt;">(Former Name or Former Address, if Changed since Last Report)</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><ix:nonNumeric contextRef="c0" format="ixt:fixed-false" name="dei:WrittenCommunications">&#9744;</ix:nonNumeric> Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><ix:nonNumeric contextRef="c0" format="ixt:fixed-false" name="dei:SolicitingMaterial">&#9744;</ix:nonNumeric> Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><ix:nonNumeric contextRef="c0" format="ixt:fixed-false" name="dei:PreCommencementTenderOffer">&#9744;</ix:nonNumeric> Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><ix:nonNumeric contextRef="c0" format="ixt:fixed-false" name="dei:PreCommencementIssuerTenderOffer">&#9744;</ix:nonNumeric> Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Securities registered pursuant to Section 12(b) of the Act:</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">	<tr>	<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 40%; border-top: 1px solid black; border-left: 1px solid black;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Title of each class</p>	</td>	<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 20%; border-top: 1px solid black; border-left: 1px solid black;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Trading Symbol(s)</p>	</td>	<td style="border-width: 1px; border-style: solid; border-color: black black rgb(0, 0, 0); vertical-align: top; width: 40%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Name of each exchange on which registered</p>	</td>	</tr>	<tr>	<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 40%; border-left: 1px solid black;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="c0" name="dei:Security12bTitle">Common Stock, $.0001 par value</ix:nonNumeric></p>	</td>	<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 20%; border-left: 1px solid black;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="c0" name="dei:TradingSymbol">IGC</ix:nonNumeric></p>	</td>	<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 40%; border-left: 1px solid black; border-right: 1px solid black;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="c0" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">NYSE American</ix:nonNumeric></p>	</td>	</tr>
</table><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1934 (&#167;240.12b-2 of this chapter)</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Emerging growth company <ix:nonNumeric contextRef="c0" format="ixt:fixed-false" name="dei:EntityEmergingGrowthCompany">&#9744;</ix:nonNumeric>.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#9744;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">&#160;</p><div>

</div><div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%">&#160;</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">&#160;</div>
</div><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align:top;width:1.3%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Item 5.02.</b></p>
			</td>
			<td style="vertical-align:top;width:8.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.</b></p>
			</td>
		</tr>

</table><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; font-variant: normal; margin: 0pt;"><b><i>PFO Employment Agreement</i></b></p><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt;">On May 5, 2023, IGC Pharma Inc. (&#8220;IGC&#8221; or the &#8220;Company&#8221;) entered into an employment agreement (the &#8220;PFO Employment Agreement&#8221;) with the Company&#8217;s Vice President and Principal Financial Officer, Ms. Claudia Grimaldi (&#8220;Executive&#8221;) (the &#8220;2023 Employment Agreement&#8221;, the &#8220;PFO Employment Agreement&#8221;). The PFO Agreement has an initial five-year term (the &#8220;Initial Term&#8221;) and will automatically renew for an additional 12-month term at the end of the Initial Term &#160;and each subsequent one-year anniversary thereafter, unless terminated by the Company or Executive pursuant to the terms of the PFO Employment Agreement.</p><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt;">The PFO Employment Agreement provides for an annual base salary of $200,000 and is subject to annual review by the Company&#8217;s Board of Directors (the (&#8220;Board&#8221;). In addition, under the PFO Employment Agreement, the Executive is eligible for an annual bonus and an annual grant of shares or options under the Company&#8217;s 2018 Omnibus Incentive Plan, as modified or revised, (the &#8220;Plan&#8221;), with vesting as determined by an award agreement and the Compensation Committee of the Board and approved by the Board.</p><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt;">Executive will be entitled to participate in all executive benefit plans maintained by the Company on substantially the same terms and conditions as other executives of the Company, including at least eight (8) days paid sick leave per year, twenty (20) days paid vacation per year, and all other holiday and leave, provided, that such time off be taken in accordance with IGC&#8217;s standard time off policies applicable to all other executives. Only vacation days not used in a twelve (12) month period will accrue and carry over to subsequent years and Executive will be eligible for vacation leave accrual payout upon termination.</p><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt;">The PFO Employment Agreement also provides that the Company must reimburse Executive for business expenses incurred in carrying out her duties and responsibilities under the PFO Employment Agreement. Also, the Company will provide Executive with the use of an automobile, plus gas and maintenance expenses, to be used by her in connection with the performance of her duties for the Company. Executive will reimburse the Company $95 per month for personal use of the automobile. The Company shall also provide the Executive with indemnity to the fullest extent permitted by law, reimbursement of business expenses, life insurance, health insurance, retirement benefits, deferred compensation, disability insurance, travel insurance, directors and officers insurance, and others as may be necessary from time to time.</p><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt;">Pursuant to the PFO Employment Agreement, if Executive resigns for &#8220;good reason&#8221; or the Company terminates Executive&#8217;s employment without &#8220;cause&#8221; or at the end of the term, does not &#8220;renew&#8221; the PFO Employment Agreement on substantially the same terms (in each case, as such term is defined in the PFO Employment Agreement), then the Company must pay Executive the greater of i) base pay for the remainder of the PFO Employment Agreement, payable over the remainder of the term in equal monthly payments, and (ii) 1.5 times the average of the total compensation, disclosed in the 10-K filed with the SEC, calculated over the previous two 10-K filings prior to termination date, with such payments to be made in eighteen equal monthly installments beginning on the first pay period following Executive&#8217;s delivery of the executed release; (iii) immediate vesting of any equity awards under the Plan that would have vested within eighteen months of the termination date had Executive&#8217;s employment not terminated; and (iv) health insurance shall continue, uninterruptedly, through the term of the PFO Employment Agreement, under the same terms as while the Executive was employed. The Company shall continue, uninterruptedly, to cover the Executive with Directors and Officers insurance (D&amp;O) coverage, consistent with the Company&#8217;s policy and coverage of other directors, for a period of 10 years. The D&amp;O coverage shall cover the years that the Executive served as the Vice President and Principal Financial Officer of the Company.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">&#160;</p><div>

</div><div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%">&#160;</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">&#160;</div>
</div><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">If Executive&#8217;s employment termination without &#8220;cause,&#8221; &#8220;non-renewal,&#8221; or &#8220;good reason resignation&#8221; occurs either (a) during a period of time when the Company is party to a fully executed letter of intent or a definitive corporate transaction agreement, the consummation of which would result in a &#8220;change in control&#8221; terms (in each case, as such term is defined in the PFO Employment Agreement) or (b) within twelve (12) months following the change in control, then the severance payment shall be 2.99 times instead of 1.5 times and shall be payable in a single cash payment on the sixtieth day following Executive&#8217;s termination date or the delivery of the executed release and all unvested equity awards under the Plan shall vest immediately.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">Executive may terminate her employment with the Company for any reason (or no reason at all) at any time by giving Company ninety (90) days prior written notice of voluntary resignation.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align:top;width:1.3%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Item 9.01.</b></p>
			</td>
			<td style="vertical-align:top;width:8.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Financial Statements and Exhibits.</b></p>
			</td>
		</tr>

</table><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">(d) <i>Exhibits.</i></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align:middle;width:3.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b><span style="text-decoration:underline">Exhibit No.</span></b></p>
			</td>
			<td style="vertical-align:middle;width:30.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b><span style="text-decoration:underline">Description</span></b></p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:3.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:middle;width:30.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:3.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">10.1*</p>
			</td>
			<td style="vertical-align:middle;width:30.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><a href="ex_514800.htm" style="-sec-extract:exhibit;">Employment&#160;Agreement, effective as of May 9, 2023, by and between IGC Pharma, Inc. and Ms. Claudia Grimaldi. **</a></p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:3.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">104</p>
			</td>
			<td style="vertical-align:middle;width:30.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Cover Page Interactive Data File (formatted as Inline XBRL)</p>
			</td>
		</tr>

</table><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">* Management contract or compensatory plan or arrangement.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">** Certain schedules or similar attachments to this exhibit have been omitted in accordance with Item 601(a)(5) of Regulation S-K.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The registrant hereby agrees to furnish supplementally to the Securities and Exchange Commission upon request a copy of any omitted schedule or attachment to this exhibit.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">&#160;</p><div>

</div><div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%">&#160;</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">&#160;</div>
</div><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>SIGNATURES</b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align:top;width:4.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td colspan="2" style="vertical-align:top;width:3.8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>IGC Pharma, Inc.</b></p>
			</td>
			<td style="vertical-align:top;width:1.2%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:4.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td colspan="2" style="vertical-align:top;width:3.8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:top;width:1.2%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:4.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:top;width:0.3%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:top;width:3.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:top;width:1.2%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:4.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Dated: May 5, 2023</p>
			</td>
			<td style="vertical-align:top;width:0.3%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">By:</p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:top;width:3.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">/s/ Ram Mukunda</p>
			</td>
			<td style="vertical-align:top;width:1.2%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:4.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:top;width:0.3%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:3.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Name: Ram Mukunda</p>
			</td>
			<td style="vertical-align:top;width:1.2%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:4.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:top;width:0.3%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:top;width:3.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Title: CEO</p>
			</td>
			<td style="vertical-align:top;width:1.2%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:4.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:top;width:0.3%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:top;width:3.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:top;width:1.2%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
		</tr>

</table><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><div class="LAST-PAGE-BREAK">
<div class="PGFTR">
<div class="hf-row">
<div class="hf-cell PGNUM">&#160;</div>
</div>
</div>
</div><div>


</div><div style="display: none"><ix:header>
<ix:hidden>
<ix:nonNumeric contextRef="c0" name="dei:AmendmentFlag">false</ix:nonNumeric>
<ix:nonNumeric contextRef="c0" name="dei:EntityCentralIndexKey">0001326205</ix:nonNumeric>
</ix:hidden>
<ix:references><link:schemaRef xlink:href="igc-20230505.xsd" xlink:type="simple"></link:schemaRef></ix:references>
<ix:resources><xbrli:context id="c0">
<!-- [WMV5][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt9uvRsJTXMeMewLyH9HKj6I6pbvcDxjLALOm5tfIsNSqwD4AozZ/F944Y87fOfI0y6vZTP3tzgy2QXberVkb2oH+mmiyBqSMiSzdFMawzswpAn9xLJSwxpmGh9i+JNdjlAkvKqUU101Y7MQNvtMJUnM3BNJMP4bvQrHrb3xpsYrtCHHkDpsrsMRceCOvoseKwQGYSXrmfWnBgjP5V2/VcP0] CSR-->
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326205</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-05-05</xbrli:startDate>
    <xbrli:endDate>2023-05-05</xbrli:endDate>
  </xbrli:period>
</xbrli:context></ix:resources></ix:header>

</div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>ex_514800.htm
<DESCRIPTION>EXHIBIT 10.1
<TEXT>
<html><head>
	<title>ex_514800.htm</title>
	<!-- Generated by ThunderDome Portal - 5/5/2023 9:08:30 PM --><meta charset="utf-8"><meta name="format-detection" content="telephone=no">
</head>
<body style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; padding: 0in 0.1in; cursor: auto;">
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"><b>Exhibit 10.1</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>2023 PFO EMPLOYMENT AGREEMENT</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">This&nbsp;<b>PFO EMPLOYMENT AGREEMENT&nbsp;</b>(this &#8220;<u>Agreement</u>&#8221;) is effective as of May 9, 2023, (the &#8220;<u>Effective Date</u>&#8221;), by and between collectively, IGC Pharma, Inc., (&#8220;<u>IGC</u>&#8221;, &#8220;Employer&#8221;, &#8220;Company&#8221;) a corporation organized under the laws of Maryland, and Claudia Grimaldi (&#8220;<u>Executive</u>&#8221;) on the following terms and conditions:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>RECITALS</b>:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">A.&nbsp;The Employer desires to be assured of the continued services of Executive; and</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">B.&nbsp;Executive desires to continue to be employed by the Employer as its Vice President, Principal Financial Officer upon the terms, covenants and conditions hereinafter set forth.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;"><b>NOW, THEREFORE,</b>&nbsp;in consideration of the mutual terms, covenants and conditions hereinafter set forth, the parties hereto agree as follows:</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">1.&nbsp;<u>Employment Period</u>.&nbsp;&nbsp;Employer hereby agrees to continue to employ Executive as its Vice President, Principal Financial Officer and Chief Compliance Officer, and Executive, agrees to accept such continued employment for the period beginning on the Effective Date and ending on the fifth anniversary of the Effective Date (the &#8220;<u>Employment Period</u>&#8221;). Thereafter, Executive&#8217;s employment shall continue until terminated in accordance with this Agreement.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>2.</b>&nbsp;<b><u>Performance of Duties</u></b><b>.</b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align:top;width:6.7%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">2.1.&nbsp;&nbsp;</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Executive agrees that during the Employment Period, and while Executive is employed by Employer, she shall devote her full normal and customary working time, energies, and talents exclusively to serving in the capacity of Vice President and Principal Financial Officer of Employer and to performing such other duties consistent with her position, as may be properly assigned to her by the Board of Directors of Employer (the &#8220;<u>Board</u>&#8221;). She will carry out such duties faithfully, efficiently and in a professional manner. The Executive, from time to time, may be assigned additional titles and responsibilities inclusive of the above and in addition to the above, such as for example, Chief Compliance Officer, Managing Director IGC Pharma SAS, Legal Representative IGC Pharma SAS, Director IGC subsidiaries, among others.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align:top;width:6.7%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">2.2.&nbsp;&nbsp;</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">In addition to the limitations imposed upon Executive by the Restrictive Covenants contained in Section 4, Executive shall not during the Employment Period and while she is employed by the Employer, without prior written consent from the Board:</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align:top;width:7.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;&nbsp;&nbsp;2.2.1.&nbsp;&nbsp;</p>
			</td>
			<td style="vertical-align:top;width:79.2%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">serve as, be a consultant to or employee, officer, manager, agent, or director of, any corporation, partnership or other entity other than Employer (other than civic, charitable, or other public service organizations) if, as determined at the reasonable discretion of the Board, such service, employment, or position would have a material adverse effect upon the ability of Executive to perform her duties hereunder and Executive is so advised in writing and given a period of not less than ninety (90) days to cease; or</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align:top;width:7.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">2.2.2.&nbsp;&nbsp;</p>
			</td>
			<td style="vertical-align:top;width:79.2%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">have more than a ten percent (10%) ownership interest in any enterprise other than Employer if such ownership interest would have a material adverse effect upon the ability of Executive to perform her duties hereunder, and the Executive is so advised in writing and given a period of not less than ninety (90) days to divest the interest.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>3.</b>&nbsp;<b><u>Compensation</u></b><b>.</b>&nbsp;&nbsp;Subject to the terms and conditions of this Agreement, Executive shall be compensated by Employer for her services as follows:</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align:top;width:6.7%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">3.1.&nbsp;&nbsp;</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Executive shall receive, for each consecutive twelve (12) month period beginning on the Effective Date and ending on each anniversary thereof, a rate of pay equal to Two Hundred Thousand Dollars ($200,000.00) per year (&#8220;Base Pay&#8221;).&nbsp;&nbsp;Such compensation shall be payable in substantially equal monthly or more frequent installments and subject to customary tax withholding. Such Base Pay may be evaluated annually.</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:6.7%;">&nbsp;</td>
			<td style="vertical-align:top;width:auto;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:6.7%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">3.2.&nbsp;&nbsp;</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Executive shall be eligible for an annual bonus and an annual grant of shares or options under the Employer&#8217;s 2018 Omnibus Incentive Plan, as modified or revised, (the &#8220;Plan&#8221;) with vesting as determined by an award agreement and the Compensation Committee and approved by the Board of the Employer.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align:top;width:6.7%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">3.3.&nbsp;&nbsp;</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Executive shall be entitled to participate in all executive benefit plans maintained by Employer on substantially the same terms and conditions as other executives of Employer including, but not limited to, plans as mentioned in Attachment 1.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align:top;width:6.7%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">3.4.&nbsp;&nbsp;</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Executive shall receive at least twenty (20) days paid vacation per year, provided, however, that such vacation shall be scheduled and taken in accordance with Employer&#8217;s standard vacation policies applicable to Employer&#8217;s other executives.&nbsp;&nbsp;Executive shall also be entitled to all other holiday and leave pay generally available to Employer&#8217;s other executives.&nbsp;&nbsp;Any vacation days not used in a twelve (12) month period shall accrue and carry over to subsequent years. Executive shall be eligible for vacation leave accrual payout upon termination.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align:top;width:6.7%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">3.5.&nbsp;&nbsp;</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Executive shall receive at least eight (8) days paid sick leave per year.&nbsp;&nbsp;Any sick leave not used in a twelve (12) month period shall accrue and carry over to subsequent years and Executive shall not be eligible for sick leave accrual payout upon termination, unless the Employer is prohibited by state law to withhold payment.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align:top;width:6.7%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">3.6.&nbsp;&nbsp;</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Executive shall be reimbursed by Employer for all reasonable business, promotional, travel and entertainment expenses incurred or paid by Executive during the Employment Period in the performance of her services under this Employment Agreement.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>4.</b>&nbsp;<b><u>Restrictive Covenants</u></b><b>.</b>&nbsp;&nbsp;Executive acknowledges and agrees that:</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align:top;width:6.7%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">4.1.&nbsp;&nbsp;</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">The agreements and covenants contained in this Section 4 are essential to protect the business interests of Employer and Employer will not enter into this Agreement but for such agreements and covenants. Accordingly, Executive covenants and agrees to the following:</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align:top;width:7.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">4.1.1.&nbsp;&nbsp;</p>
			</td>
			<td style="vertical-align:top;width:79.2%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Confidential Information.&nbsp;&nbsp;Except as may be required by the lawful order of a court, regulatory body or similar agency of competent jurisdiction, and at the sole cost and expense of the Employer, if any, unless disclosed with the Employer&#8217;s permission, Executive agrees to keep secret and confidential, during the Employment Period and while she is employed by Employer, all confidential non-public information of Employer, and its respective affiliates that was acquired by, or disclosed to (&#8220;Confidential Information&#8221;), Executive during the course of her employment by Employer or any of its affiliates, including information relating to customers (including, without limitation, credit history, repayment history, financial information and financial statements), costs, operations, financial data and plans, and employee information, whether past, current or planned, and not to disclose the same, either directly or indirectly, to any other person, firm or business entity, or to use it in any way; provided, however, that the provisions of this Section 4.1.1 shall not apply to information that:&nbsp;&nbsp;(A) was, is now, or becomes generally available to the public (but not as a result of a breach of any duty of confidentiality by which Executive is bound); (B) was disclosed to Executive by a third party not subject to any duty of confidentiality to Employer prior to its disclosure to Executive; (C) is disclosed by Executive in the ordinary course of Employer&#8217;s business as a proper part of her employment in connection with communications with customers, vendors and other proper parties, provided that it is for a proper business purpose solely for the benefit of Employer.&nbsp;&nbsp;Executive further agrees that she shall not make any statement or disclosure that is intended by Executive to be detrimental to Employer or any of its affiliates. Executive agrees to observe all reasonable policies and procedures of the Employer that are provided to her concerning such Confidential Information.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align:top;width:6.7%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">4.1.2.&nbsp;&nbsp;</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Non-Competition and Non-Solicitation.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align:top;width:10%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">4.1.2.1.&nbsp;&nbsp;</p>
			</td>
			<td style="vertical-align:top;width:76.7%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Executive agrees that for the period commencing on the Effective Date and ending on the first anniversary of the date on which Executive&#8217;s employment with Employer is terminated for any reason or no reason (the &#8220;<u>Non-Competition Period</u>&#8221;), Executive shall not directly or indirectly, alone or as a partner, officer, director, manager, employee, consultant, agent, independent contractor, member or stockholder of any person or entity (&#8220;<u>Person</u>&#8221;), engage in any business activity in the geographic areas where the Business is located that is directly or indirectly in competition with the Business (as defined herein) of Employer or which is known by Executive to be detrimental to the Business or business plans of Employer or its affiliates; provided, however, that the record or beneficial ownership by Executive or her immediate family members of five percent (5%) or less of the outstanding publicly traded capital stock of any company for investment purposes shall not be deemed to be in violation of this Section 4.1.2.1 so long as Executive is not an officer, director, manager, employee or consultant of such Person.&nbsp;&nbsp;</p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">The Employer&#8217;s business is described in its SEC filings from time to time.</p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">The Employer develops advanced cannabinoid-based formulations for treating diseases and conditions, including, but not limited to, Alzheimer's disease, period cramps ("dysmenorrhea"), premenstrual syndrome ("PMS") and chronic pain. IGC has two investigational drug assets targeting Alzheimer's disease, IGC-AD1 and TGR-63, which have demonstrated in Alzheimer's cell lines the potential to be effective in suppressing or ameliorating key hallmarks of Alzheimer's disease, such as plaques or tangles. IGC-AD1 is a low-dose tetrahydrocannabinol ("THC") based formulation that is currently in a 146-person Phase 2 clinical trial for agitation in dementia due to Alzheimer's (clinicaltrials.gov, NCT05543681). IGC also markets a wellness brand, Holief&#8482;, that targets women experiencing premenstrual syndrome and menstrual cramps. Geographically, the business is based in the United States, India and Colombia, South America, and may expand to other countries.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align:top;width:10%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>
			</td>
			<td style="vertical-align:top;width:76.7%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Executive further agrees that during the Non-Competition Period, she shall not in any capacity, either separately or in association with others:&nbsp;&nbsp;(1) employ or solicit for employment or endeavor in any way to entice away from employment with Employer or its affiliates (a) any current employee of Employer or its affiliates or (b) any Person who was employed by Employer or its affiliates in any preceding 12-month period; (2) solicit, induce or influence any supplier, customer, agent, consultant or other Person that has a business relationship with Employer to discontinue, reduce or modify such relationship with Employer; nor (3) solicit or enter into negotiations with any of Employer&#8217;s identified potential acquisition candidates.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align:top;width:10%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">4.1.2.2.&nbsp;&nbsp;</p>
			</td>
			<td style="vertical-align:top;width:76.7%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Executive understands that the foregoing restrictions may limit her ability to engage in a business similar to Employer&#8217;s Business for the duration of the Non-Competition Period but acknowledges that she will receive sufficiently high remuneration and other benefits to justify such restriction as an employee of Employer pursuant to this Agreement.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align:top;width:10%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">4.1.2.3.&nbsp;&nbsp;</p>
			</td>
			<td style="vertical-align:top;width:76.7%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Notwithstanding the generality of any other provision of this Agreement, during the Non-Competition Period, it shall not be a violation of Section 2.2 or this Section 4 for Executive to (i) be an owner, partner, officer, director, manager, employee, consultant, agent, independent contractor, member or stockholder of any person or entity that does not compete with the Business of Employer or (ii) make unlimited investments with other family members in any person or entity that does not compete with the Business of Employer.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align:top;width:6.7%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">4.1.3.&nbsp;&nbsp;</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Remedies.&nbsp;&nbsp;If Executive breaches any of the provisions contained in Sections 4.1.1 or 4.1.2 (the &#8220;<u>Restrictive Covenants</u>&#8221;), Employer shall have the following rights and remedies, each of which shall be enforceable, and each of which is in addition to, and not in lieu of, any other rights and remedies available to Employer at law or in equity.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align:top;width:10%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">4.1.3.1.&nbsp;&nbsp;</p>
			</td>
			<td style="vertical-align:top;width:76.7%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Executive shall account for and pay over to Employer all compensation, profits, and other benefits which inure to Executive&#8217;s benefit which are derived or received by Executive or any person or business entity controlled by Executive, resulting from any action or transactions constituting a breach of any of the Restrictive Covenants.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align:top;width:10%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">4.1.3.2.&nbsp;&nbsp;</p>
			</td>
			<td style="vertical-align:top;width:76.7%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Notwithstanding the provisions of Section 4.1.3.1 above, Executive acknowledges and agrees that in the event of a violation or Executive&#8217;s threatened violation of any of the Restrictive Covenants, Employer shall have no adequate remedy at law and shall therefore be entitled to enforce each such provision by temporary or permanent injunction or mandatory relief obtained in any court of competent jurisdiction without the necessity of proving damages, posting any bond or other security, and without prejudice to any other rights and remedies that may be available at law or in equity.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align:top;width:6.7%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">4.1.4.&nbsp;&nbsp;</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Severability.&nbsp;&nbsp;If any of the Restrictive Covenants, or any part thereof, are held to be invalid or unenforceable, the same shall not affect the remainder of the covenant or covenants, which shall be given full effect, without regard to the invalid or unenforceable portions. Without limiting the generality of the foregoing, if any of the Restrictive Covenants, or any part thereof, are held to be unenforceable because of the duration of such provision or the area covered thereby, the parties hereto agree that the court making such determination shall have the power to reduce the duration and/or area of such provision and, in its reduced form, such provision shall then be enforceable.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align:top;width:6.7%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">4.1.5.&nbsp;&nbsp;</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Proprietary Rights.&nbsp;&nbsp;Executive acknowledges and agrees that all know-how, documents, reports, plans, proposals, marketing and sales plans, client lists, employee files, client files, and any materials made by Executive or by Employer during the period of Executive&#8217;s employment are the property of Employer and shall not be used by Executive in any way adverse to Employer&#8217;s interests while she is so employed by Employer.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>5.</b>&nbsp;<b><u>Termination and Compensation Due Upon Termination</u></b><b>.</b>&nbsp;&nbsp;Executive&#8217;s right to compensation for the period after the date Executive&#8217;s employment with Employer terminates shall be determined in accordance with the following:</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align:top;width:6.7%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">5.1.&nbsp;&nbsp;</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Termination Without Cause, Non-Renewal, or for Good Reason.&nbsp;&nbsp;In the event Employer terminates Executive&#8217;s employment during the Employment Period without Cause, or at the end of the term, does not renew the Employment Agreement on substantially the same terms or Executive resigns her employment for Good Reason, Executive shall receive the following (only if and subject to Executive&#8217;s execution and delivery of a general release of claims):</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align:top;width:9.2%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">5.1.1.&nbsp;&nbsp;</p>
			</td>
			<td style="vertical-align:top;width:77.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">the greater of a) base pay for the remainder of this Agreement, payable over the remainder of the term in equal monthly payments or b) 1.5 times the average of the total compensation, disclosed in the 10-K filed with the SEC, calculated over the previous two 10-K filings prior to termination date. , with such payments shall be made in eighteen equal monthly installments; beginning on the first pay period following Executive&#8217;s delivery of the executed release;</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align:top;width:9.2%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">5.1.2.&nbsp;&nbsp;</p>
			</td>
			<td style="vertical-align:top;width:77.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">vesting of any equity awards under the Plan that would have vested within eighteen months of the termination date had Executive&#8217;s employment not been terminated;</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align:top;width:9.2%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">5.1.3.&nbsp;&nbsp;</p>
			</td>
			<td style="vertical-align:top;width:77.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">health insurance shall continue, uninterruptedly, through the term of this Agreement, under the same terms as while the Executive was employed.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align:top;width:9.2%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">5.1.4.&nbsp;&nbsp;</p>
			</td>
			<td style="vertical-align:top;width:77.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">The Employer shall continue, uninterruptedly, to cover the Executive with Directors and Officers insurance (D&amp;O) coverage, consistent with the Employer&#8217;s policy and coverage of other directors, for a period of 10 years. The D&amp;O coverage shall cover the years that the Executive served as the Vice President, Principal Financial Officer, of the Employer, and any other titles and responsibilities assumed by the Executive during the term of employment.</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 9.2%; text-align: justify;">&nbsp;</td>
			<td style="vertical-align: top; width: 77.5%; text-align: justify;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:9.2%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">5.1.5.&nbsp;&nbsp;</p>
			</td>
			<td style="vertical-align:top;width:77.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">If the Termination with Cause, Non-Renewal, or Good Reason resignation occurs either (a) during a period of time when the Employer is party to a fully executed letter of intent or a definitive corporate transaction agreement, the consummation of which would result in a Change in Control or (b) within twelve (12) months following the Change in Control, then the severance payment under 5.1.1 shall be 2.99 times the payment set out in 5.1.1 instead of 1.5 times and shall be payable in a single cash lumpsum on the sixtieth day following Executive&#8217;s termination date or the delivery of the executed release and all unvested equity awards under the Plan shall vest immediately. &#8220;Change in Control&#8221;&nbsp;shall mean each of the following with respect to the Employer: (i) a sale of all or substantially all of the Employer&#8217;s assets; (ii) a sale of the voting securities of the Employer such that any person or group of persons who did not hold voting securities of the Employer prior to the transaction hold more than fifty percent (50%) of the combined voting power of the securities of the Employer after the transaction; or (iii) any merger, consolidation or other transaction of the Employer with or into another corporation or other entity, other than a transaction in which the holders of voting securities of the Employer immediately prior to such transaction continue to represent (either by remaining outstanding or by being converted into voting securities of the surviving entity or any parent thereof), at least fifty percent (50%) of the combined voting power of the securities of the Employer or such surviving entity or parent thereof immediately after such transaction.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align:top;width:6.7%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">5.2.&nbsp;&nbsp;</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Voluntary Resignation.&nbsp;&nbsp;Executive may terminate her employment with Employer for any reason (or no reason at all) at any time by giving Employer ninety (90) days prior written notice of voluntary resignation; provided, however, that Employer may decide that Executive&#8217;s voluntary resignation be effective immediately upon notice of such resignation. Employer shall have no obligation to make payments to Executive in accordance with the provisions of Section 3 for periods after the date on which Executive&#8217;s employment terminates due to Executive&#8217;s voluntary resignation, including in the event Employer accelerates the effectiveness of the resignation in accordance with this Section 5.2.&nbsp;&nbsp;</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align:top;width:6.7%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">5.3.&nbsp;&nbsp;</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">For purposes of this Section 5, Good Reason shall mean the occurrence of any of the following events (a &#8220;Good Reason Condition&#8221;), subject to having complied with the Good Reason Process (as defined below), without Executive&#8217;s consent:</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align:top;width:9.2%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">5.3.1.&nbsp;&nbsp;</p>
			</td>
			<td style="vertical-align:top;width:77.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Executive is no longer the Vice President, and Principal Financial Officer or the Executive reports to any individual other than the Chief Executive Officer, Board of Directors, or Executive Chairman, without her consent;</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align:top;width:9.2%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">5.3.2.&nbsp;&nbsp;</p>
			</td>
			<td style="vertical-align:top;width:77.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">the relocation of Executive&#8217;s office more than hundred (100) miles from its current headquarters in Potomac, Maryland without Executive&#8217;s consent;</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align:top;width:9.2%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">5.3.3.&nbsp;&nbsp;</p>
			</td>
			<td style="vertical-align:top;width:77.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">a material breach of any of the provisions of this Agreement by the Employer.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align:top;width:9.2%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">5.3.4.&nbsp;&nbsp;</p>
			</td>
			<td style="vertical-align:top;width:77.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Good Reason Process shall mean (i) Executive reasonably determines in good faith that a Good Reason Condition has occurred; (ii) Executive notifies the Employer in writing within sixty days of such determination; (iii) the Employer is afforded a period of not less than thirty days following such notice (the &#8220;Cure Period&#8221;) to remedy the Good Reason Condition; and (iv) the Good Reason Condition continues to exist at the end of the Cure Period; and (v) Executive terminates her employment for such Good Reason Condition within sixty days after the end of the Cure Period. If the Employer cures the Good Reason Condition during the Cure Period, Good Reason shall be deemed not to have occurred.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align:top;width:6.7%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">5.4.&nbsp;&nbsp;</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Termination for Cause.&nbsp;&nbsp;Employer shall have no obligation to make payments to Executive in accordance with the provisions of Section 3 or otherwise for periods after Executive&#8217;s employment with Employer is terminated because of Executive&#8217;s termination for Cause. For purposes of this Section 5.4, Executive shall be considered terminated for &#8220;Cause&#8221;&nbsp;if she is discharged by Employer on account of the occurrence of one or more of the following events:</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align:top;width:9.2%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">5.4.1.&nbsp;&nbsp;</p>
			</td>
			<td style="vertical-align:top;width:77.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">her commission at any time of any act or omission that results in a conviction or plea of no contest for any felony or crime involving moral turpitude;</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align:top;width:9.2%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">5.4.2.&nbsp;&nbsp;</p>
			</td>
			<td style="vertical-align:top;width:77.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">her commission at any time of any act of fraud, embezzlement, willful misappropriation of material Employer property, or willful and material misconduct;</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align:top;width:9.2%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">5.4.3.&nbsp;&nbsp;</p>
			</td>
			<td style="vertical-align:top;width:77.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Executive commits an act of fraud against Employer, violates a duty of loyalty to Employer, or violates an obligation owed to Employer pursuant to Sections 2 or 4 hereof;</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align:top;width:9.2%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">5.4.4.&nbsp;&nbsp;</p>
			</td>
			<td style="vertical-align:top;width:77.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">willful and material breach of the Executive&#8217;s obligations under any material agreement entered into between the Executive and the Employer or any of its affiliates (including under this Agreement), or willful and material breach of the Employer&#8217;s polices or procedures which causes material damage or could be reasonably expected to cause material damage to the Employer, its business or reputation;</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align:top;width:9.2%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">5.4.5.&nbsp;&nbsp;</p>
			</td>
			<td style="vertical-align:top;width:77.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">willful and repeated failure to substantially perform Executive&#8217;s material duties as are reasonably assigned to her by the Board (other than due to Executive&#8217;s illness or disability), provided that for Sections 5.4.4 and 5.4.5 and (D), if the breach reasonably may be cured, Executive has been given at least thirty (30) days after Executive&#8217;s receipt of written notice of such breach from the Employer to cure such breach. Such written notice shall state in reasonable detail the particular acts or failures to act that constitute the grounds on which the proposed termination for Cause is based. No matter may be alleged to constitute Cause unless such written notice is provided to Executive within sixty days after the Employer is in possession of the material information upon which the allegation of Cause is based. Whether or not such breach has been cured will be determined in the reasonably good faith judgment of the Board. If Executive cures, Cause shall be deemed not to have occurred.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align:top;width:6.7%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">5.5.&nbsp;&nbsp;</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Employer shall have no obligation to make payments to Executive in accordance with the provisions of Section 3 for periods after the date of Executive&#8217;s death, except payments due and owing as of such date.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>6.</b>&nbsp;<b><u>Indemnification</u></b><b>.</b>&nbsp;&nbsp;Executive shall be defended, held harmless by and indemnified by Employer to the fullest extent permitted by applicable law (including, but not limited to payment of all legal fees and costs and by counsel reasonably satisfactory to her) against claims asserted against her by third parties, arising out of, or related to, the business of the Employer or Executive&#8217;s services for Employer or its affiliates, where such services were within the scope of authority of Employee, or specifically authorized in advance by Employer.&nbsp;&nbsp;However, Employer shall have no obligation to defend, indemnify or hold Executive harmless from any claims relying in whole or in part upon any intentionally tortious, grossly negligent, or fraudulent conduct by Executive.&nbsp;&nbsp;This duty of indemnification shall survive the termination of this Agreement for a period of two years and is intended to be in addition to and not in lieu of any indemnification right of Executive that may be contained in the Bylaws or Articles of Incorporation of Employer.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>7. </b><b><u>Section 409A</u></b>. The intent of the parties is that payments and benefits under this Agreement comply with, or be exempt from, Section 409A of the Internal Revenue Code of 1986, as amended (the &#8220;Code&#8221;) and the regulations and guidance promulgated thereunder (collectively &#8220;Code Section 409A&#8221;) and, accordingly, to the maximum extent permitted, this Agreement shall be interpreted and administered accordingly. A termination of employment shall not be deemed to have occurred for purposes of any provision of this Agreement providing for the payment of any amounts or benefits upon or following a termination of employment that are considered &#8220;nonqualified deferred compensation&#8221; under Code Section 409A unless such termination is also a &#8220;separation from service&#8221; within the meaning of Code Section 409A and, for purposes of any such provision of this Agreement, references to a &#8220;termination,&#8221; &#8220;termination of employment&#8221; or like terms shall mean &#8220;separation from service.&#8221; With regard to any provision herein that provides for reimbursement of costs and expenses or in-kind benefits, except as permitted by Code Section 409A, (i) the right to reimbursement or in-kind benefits shall not be subject to liquidation or exchange for another benefit, (ii) the amount of expenses eligible for reimbursement, or in-kind benefits, provided during any taxable year shall not affect the expenses eligible for reimbursement, or in-kind benefits to be provided, in any other taxable year, provided that the foregoing clause (ii) shall not be violated without regard to expenses reimbursed under any arrangement covered by Code Section 105(b) solely because such expenses are subject to a limit related to the period the arrangement is in effect and (iii) such payments shall be made on or before the last day of Executive&#8217;s taxable year following the taxable year in which the expense occurred. For purposes of Code Section 409A, Executive&#8217;s right to receive any installment payments pursuant to this Agreement shall be treated as a right to receive a series of separate and distinct payments. Whenever a payment under this Agreement specifies a payment period with reference to a number of days (e.g., &#8220;within sixty (60) days following the date of termination&#8221;), the actual date of payment within the specified period shall be within the sole discretion of the Employer. If Executive is a specified employee within the meaning of Section 409A(a)(2)(B)(i) of the Code and would receive any payment sooner than 6 months after Executive&#8217;s &#8220;separation from service&#8221; that, absent the application of this Section 15(e), would be subject to additional tax imposed pursuant to Section 409A of the Code as a result of such status as a specified employee, then such payment shall instead be payable on the date that is the earliest of (i) 6 months after Executive&#8217;s &#8220;separation from service,&#8221; or (ii) Executive&#8217;s death.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>8. </b><b><u>Section 280G</u></b><b>.</b> In the event that any payments, distributions, benefits or entitlements of any type payable to Executive (the &#8220;Total Payments&#8221;) would (i) constitute &#8220;parachute payments&#8221; within the meaning of Section 280G of the Code (which will not include any portion of payments allocated to the restrictive covenant provisions of Section 10 hereof that are classified as payments of reasonable compensation for purposes of Section 280G of the Code), and (ii) but for this paragraph would be subject to the excise tax imposed by Section 4999 of the Code (the &#8220;Excise Tax&#8221;), then the Total Payments shall be either: (a) provided in full, or (b) provided as to such lesser extent as would result in no portion of such Total Payments being subject to the Excise Tax, whichever of the foregoing amounts, taking into account the applicable federal, state and local income taxes and the Excise Tax, results in Executive&#8217;s receipt on an after-tax basis of the greatest amount of the Total Payments, notwithstanding that all or some portion of the Total Payments may be subject to the Excise Tax. Unless the Employer and Executive otherwise agree in writing, any determination required under this Section 8 shall be made in writing in good faith based on the advice of a nationally recognized accounting firm selected by the Employer (with approval of Executive) (the &#8220;Accountants&#8221;). In the event of a reduction of benefits hereunder, benefits shall be reduced by first reducing or eliminating the portion of the Total Payments that are payable in cash under Section 7 and then by reducing or eliminating any amounts that are payable with respect to long-term incentives including any equity-based or equity-related awards (whether payable in cash or in</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">kind). For purposes of making the calculations required by this Section 8, the Accountants may make reasonable assumptions and approximations concerning applicable taxes and may rely on reasonable, good faith interpretations concerning the application of the Code, and other applicable legal authority. The Employer and Executive shall furnish to the Accountants such information and documents as the Accountants may reasonably require in order to make a determination under this Section 8, and the Employer shall bear the cost of all fees the Accountants charge in connection with any calculations contemplated by this Section 8.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>9.</b>&nbsp;<b><u>Assignment of Intellectual Property</u></b><b>.</b> Executive will promptly disclose to the Employer any idea, invention, discovery or improvement, whether patentable or not (&#8220;Creations&#8221;), conceived or made by her alone or with others at any time during her employment with the Employer. Executive agrees that the Employer owns any such Creations, and Executive hereby irrevocably, absolutely, and unconditionally assigns to the Employer all rights, title and interest in and to the Creations or portions thereof, including but not limited to, all copyrights, patents, and other proprietary and intellectual property rights and any and all goodwill associated therewith, as well as all moral rights that Executive has or may acquire in and/or to the Creations, or any of them, including but not limited to any and all rights of identification of authorship and any and all rights of approval, restriction or limitation on use or subsequent modifications relating to the Creations. Executive agrees to execute and deliver to Employer any and all applications, assignments and other instruments relating thereto which the Employer deems necessary or desirable in its discretion. These obligations shall continue beyond the termination of her employment with respect to Creations and derivatives of such Creations conceived or made during her employment with the Employer. The Employer and Executive understand that the obligation to assign Creations to the Employer shall not apply to any Creation which is developed entirely on her own time without using any of the Employer&#8217;s equipment, supplies, facilities, and/or Confidential Information (&#8220;Executive Creations&#8221;) unless such Creation (i) relates in any way to the business or to the current or anticipated research or development of the Employer; or (ii) results in any way from her work at the Employer. In any jurisdiction in which moral rights cannot be assigned, Executive hereby waives any such moral rights and any similar or analogous rights under the applicable laws of any country of the world that Executive may have in connection with the Creations, and to the extent such waiver is unenforceable, hereby covenants and agrees not to bring any claim, suit or other legal proceeding against the Employer or any of its Affiliated Entities claiming that Executive&#8217;s moral rights to the Creations have been violated. Executive agrees to reasonably cooperate with the Employer, both during and after her employment with the Employer, with respect to the procurement, maintenance and enforcement of copyrights, patents, trademarks and other intellectual property rights (both in the United States and foreign countries) relating to Creations covered by Section 9 hereof. Executive shall sign all papers, including, without limitation, copyright applications, patent applications, declarations, oaths, formal assignments, assignments of priority rights and powers of attorney, which the Employer, acting reasonably, may deem necessary or desirable in order to protect its rights and interests in any such Creations. Executive further agrees that if the Employer is unable, after reasonable effort, to secure Executive&#8217;s signature on any such papers, any officer of the Employer shall be entitled to execute such papers as her agent and attorney-in-fact and Executive hereby irrevocably designates and appoints each officer of the Employer as her agent and attorney-in-fact to execute any such papers on her behalf and to take any and all actions as the Employer may deem necessary or desirable in order to protect its rights and interests in any such Creations, under the conditions described in this paragraph, all to the exclusion of such Executive&#8217;s Creations.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>10. </b><b><u>Assignment and Successors</u></b><b>.</b>&nbsp;&nbsp;This Agreement is a personal contract and Executive may not sell, transfer, assign, pledge, or hypothecate her rights, interests, and obligations hereunder. Except as otherwise herein expressly provided, this Agreement shall be binding upon and shall inure to the benefit of Executive and her personal representatives and shall inure to the benefit of and be binding upon the Employer and its successors and assigns, except that the Employer may not assign this Agreement without Executive&#8217;s prior written consent, except to an acquirer of all or substantially all of the assets of the Employer.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>11.</b>&nbsp;<b><u>Governing Law</u></b><b>.</b>&nbsp;&nbsp;This agreement will be governed by and construed in accordance with the laws of the state of Maryland without reference to the principles of conflicts of laws or any other principle that could result in the application of the laws of any other jurisdiction. The parties agree to submit any dispute, claim or controversy relating to this Agreement, Executive&#8217;s employment or the termination thereof to arbitration under the Employment Arbitration Rules of the American Arbitration Association, which shall have exclusive jurisdiction over such dispute. The parties agree to enter into mediation prior to arbitration.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>12.</b>&nbsp;<b><u>Entire Agreement</u></b><b>.</b>&nbsp;&nbsp;This Agreement embodies the entire agreement of the parties respecting the matters within its scope. This Agreement supersedes all prior agreements of the parties on this subject matter . Any prior negotiations, correspondence, agreements, proposals, or understandings relating to the subject matter shall be deemed to be merged into this Agreement and to the extent inconsistent herewith, such negotiations, correspondence, agreements, proposals or understandings shall be deemed to be of no force or effect. There are no representations, warranties or agreements, whether express or implied, or oral or written, with respect to the subject matter, except as set forth herein.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>13.</b>&nbsp;<b><u>Modifications</u></b><b>.</b>&nbsp;&nbsp;This Agreement shall not be modified by any oral agreement, either express or implied, and all modifications shall be in writing and signed by the parties.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>14.</b>&nbsp;<b><u>Waiver</u></b><b>.</b>&nbsp;&nbsp;Failure to insist upon strict compliance with any of the terms, covenants or conditions shall not be deemed a waiver of such terms, covenant, or condition, nor shall any waiver or relinquishment of, or failure to insist upon strict compliance with, any right or power at any one or more times be deemed a waiver or relinquishment of such right or power at any other time or times. All waivers shall be in writing and signed by Executive and Employer.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>15.</b>&nbsp;<b><u>Number and Gender</u></b><b>.</b>&nbsp;&nbsp;Where the context requires, the singular shall include the plural, the plural shall include the singular, and any gender shall include all other genders.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>16.</b>&nbsp;<b><u>Headings</u></b><b>.</b>&nbsp;&nbsp;The section and Section headings in this Agreement are for the purpose of convenience only and shall not limit or otherwise affect any of its terms.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>17.</b>&nbsp;<b><u>Attorneys</u></b><u>&#8217;</u><b><u> Fees</u></b><b>.</b>&nbsp;&nbsp;Executive and the Employer agree that in any dispute resolution proceedings arising out of this Agreement, the prevailing party shall be entitled to its or her reasonable attorneys&#8217; fees and costs incurred by it or</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>18.</b>&nbsp;<b><u>Severability</u></b><b>.</b>&nbsp;&nbsp;In the event that it is determined that any portion of this Agreement is in violation of any statute or public policy, then only the portions of this Agreement which violate such statute or public policy shall be stricken, and all portions of this Agreement which do not violate any statute or public policy shall continue in full force and effect. Furthermore, any determination striking any portion of this Agreement shall be done as narrowly as possible so as to give as much effect as possible to the intentions of the parties under this Agreement.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>19.</b>&nbsp;<b><u>Counterparts</u></b><b>.</b>&nbsp;&nbsp;This Agreement may be executed in any number of counterparts, each of which shall be deemed an original and all of which together shall constitute one and the same document.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>20.</b>&nbsp;<b><u>Notices</u></b><b>.</b>&nbsp;&nbsp;All notices and other communications provided for in the Agreement shall be in writing and will be deemed duly given (a) when delivered by hand or electronic mail, (b) two (2) days after being given to an express courier with a reliable system for tracking delivery, (c) when sent by confirmed facsimile with a copy sent by another means specified in this provision or (d) five (5) days after the day of mailing, when mailed by registered or certified mail, return receipt requested, postage prepaid, and addressed as set forth below. A party may from time to time change its address or designee for notification purposes by giving the other written notice of the new address or designee and the date upon which it will become effective. The addresses for such notices shall be:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">20.1.&nbsp; &nbsp; &nbsp; &nbsp;If to Executive:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 36pt;">5903 Barbados Place #201</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 36pt;">North Bethesda, MD&nbsp;&nbsp;20852</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">Attention:&nbsp;&nbsp;Claudia Grimaldi</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 36pt;">with a copy to:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">20.2.&nbsp; &nbsp; &nbsp; &nbsp;If to Employer:&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">10224 Falls Road</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">Potomac, MD 20854</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">Attention:&nbsp;&nbsp;Board</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>21.</b>&nbsp;<b><u>Time of the Essence</u></b><b>.</b>&nbsp;&nbsp;Time is expressly made of the essence with respect to each and every provision of the Agreement.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>22.</b>&nbsp;<b><u>Inurement</u></b><b>.</b>&nbsp;&nbsp;Except as otherwise specified herein, no Person, other than the parties (and Executive&#8217;s estate upon her death, including her personal representative, administrator, or heirs), shall have any rights under or interest in this Agreement or its subject matter.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>[SIGNATURE PAGE FOLLOWS]</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%">&nbsp;</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">&nbsp;</div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>IN WITNESS WHEREOF</b>, the undersigned have executed this PFO Employment Agreement as of the Effective Date.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>IGC Pharma, Inc.</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">By:&nbsp;<u> &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;&nbsp;</u></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Name: Ram Mukunda&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Title:&nbsp;&nbsp;Chief Executive Officer &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">By: <u>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;&nbsp;</u></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Name:&nbsp;Claudia Grimaldi</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Title: Executive&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>ATTACHMENT 1:</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Section 3.5:&nbsp;&nbsp;&nbsp;The Employer shall have the use of a Company car inclusive of maintenance, gas, insurance, among others. The car is to be used by Executive in connection with the performance of her duties for Employer. The Employee may use the vehicle for personal use and shall reimburse the Employer $95 per month for personal use of the automobile.&nbsp; The Employer shall also provide the Executive with indemnity to the fullest extent permitted by law, reimbursement of business expenses, life insurance, health insurance, retirement benefits, deferred compensation, disability insurance, travel insurance, directors and officers insurance, and others as may be necessary from time to time.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="LAST-PAGE-BREAK">
<div class="PGFTR">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>
</div>


</body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>igc-20230505.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Fri May 05 21:45:25 UTC 2023 -->
<xs:schema elementFormDefault="qualified" xmlns:srt-types="http://fasb.org/srt-types/2023" targetNamespace="http://www.igcinc.us/20230505" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:us-types="http://fasb.org/us-types/2023" xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:igc="http://www.igcinc.us/20230505" xmlns:dtr="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xlink:type="simple" xlink:href="igc-20230505_lab.xml" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="igc-20230505_pre.xml" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="igc-20230505_def.xml" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef"/>
<!-- [WMV5][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt9uvRsJTXMeMewLyH9HKj6I6pbvcDxjLALOm5tfIsNSqwD4AozZ/F944Y87fOfI0y6vZTP3tzgy2QXberVkb2oH+mmiyBqSMiSzdFMawzswpAn9xLJSwxpmGh9i+JNdjlAkvKqUU101Y7MQNvtMJUnM3BNJMP4bvQrHrb3xpsYrtCHHkDpsrsMRceCOvoseKwTN2fMVcZMM4Ad3ooR0cx7b] CSR-->
      <link:roleType roleURI="http://www.igcinc.us/role/DocumentAndEntityInformation" id="DocumentAndEntityInformation">
        <link:definition>000 - Document - Document And Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://fasb.org/us-types/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://fasb.org/srt-types/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/sic/2023" schemaLocation="https://xbrl.sec.gov/sic/2023/sic-2023.xsd"/>
  <xs:element name="DocumentAndEntityInformationAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="igc_DocumentAndEntityInformationAbstract"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>4
<FILENAME>igc-20230505_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Fri May 05 21:45:25 UTC 2023 -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:xbrldt="http://xbrl.org/2005/xbrldt">
  <roleRef xlink:type="simple" xlink:href="igc-20230505.xsd#DocumentAndEntityInformation" roleURI="http://www.igcinc.us/role/DocumentAndEntityInformation"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all"/>
  <definitionLink xlink:type="extended" xlink:role="http://www.igcinc.us/role/DocumentAndEntityInformation">
    <loc xlink:type="locator" xlink:label="dei_DocumentInformationLineItems" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationLineItems"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentInformationTable" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentInformationTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityRegistrantName" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_TradingSymbol" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentType" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AmendmentFlag" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCentralIndexKey" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityEmergingGrowthCompany" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityIncorporationStateCountryCode" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber"/>
<!-- [WMV5][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt9uvRsJTXMeMewLyH9HKj6I6pbvcDxjLALOm5tfIsNSqwD4AozZ/F944Y87fOfI0y6vZTP3tzgy2QXberVkb2oH+mmiyBqSMiSzdFMawzswpAn9xLJSwxpmGh9i+JNdjlAkvKqUU101Y7MQNvtMJUnM3BNJMP4bvQrHrb3xpsYrtCHHkDpsrsMRceCOvoseKwRZkKjzCY8zSdDS7GgHT8qA] CSR-->
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFileNumber" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityTaxIdentificationNumber" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressAddressLine1" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressCityOrTown" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressStateOrProvince" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressPostalZipCode" order="14" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CityAreaCode" order="15" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_LocalPhoneNumber" order="16" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityInformationFormerLegalOrRegisteredName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInformationFormerLegalOrRegisteredName"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityInformationFormerLegalOrRegisteredName" order="17" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_WrittenCommunications" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_WrittenCommunications" order="18" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_SolicitingMaterial" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SolicitingMaterial" order="19" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_PreCommencementTenderOffer" order="20" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_PreCommencementIssuerTenderOffer" order="21" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_Security12bTitle" order="22" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SecurityExchangeName" order="23" xbrldt:closed="true"/>
  </definitionLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>igc-20230505_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Fri May 05 21:45:25 UTC 2023 -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <loc xlink:type="locator" xlink:label="dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityInformationFormerLegalOrRegisteredName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInformationFormerLegalOrRegisteredName"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityInformationFormerLegalOrRegisteredName_lbl" xml:lang="en-US">Entity Information, Former Legal or Registered Name</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInformationFormerLegalOrRegisteredName" xlink:to="dei_EntityInformationFormerLegalOrRegisteredName_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_WrittenCommunications" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_SolicitingMaterial" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</label>
<!-- [WMV5][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt9uvRsJTXMeMewLyH9HKj6I6pbvcDxjLALOm5tfIsNSqwD4AozZ/F944Y87fOfI0y6vZTP3tzgy2QXberVkb2oH+mmiyBqSMiSzdFMawzswpAn9xLJSwxpmGh9i+JNdjlAkvKqUU101Y7MQNvtMJUnM3BNJMP4bvQrHrb3xpsYrtCHHkDpsrsMRceCOvoseKwReGlwwkrOn3SbZs81gBUhP] CSR-->
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl0" xml:lang="en-US">City Area Code</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl0" xml:lang="en-US">Document Type</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl0" xml:lang="en-US">Entity Address, City or Town</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl0" xml:lang="en-US">Entity Tax Identification Number</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl0" xml:lang="en-US">Entity Address, Postal Zip Code</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl0" xml:lang="en-US">Entity File Number</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl0" xml:lang="en-US">Entity Emerging Growth Company</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl0" xml:lang="en-US">Amendment Flag</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl0" xml:lang="en-US">Document Period End Date</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInformationFormerLegalOrRegisteredName_lbl0" xml:lang="en-US">Entity Information, Former Legal or Registered Name</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInformationFormerLegalOrRegisteredName" xlink:to="dei_EntityInformationFormerLegalOrRegisteredName_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl0" xml:lang="en-US">Soliciting Material</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl0" xml:lang="en-US">Written Communications</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl0" xml:lang="en-US">Pre-commencement Tender Offer</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl0" xml:lang="en-US">Title of 12(b) Security</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl0" xml:lang="en-US">Entity Address, State or Province</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl0" xml:lang="en-US">Trading Symbol</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl0" xml:lang="en-US">Entity Address, Address Line One</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl0" xml:lang="en-US">Pre-commencement Issuer Tender Offer</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl0" xml:lang="en-US">Entity Registrant Name</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl0" xml:lang="en-US">Entity Incorporation, State or Country Code</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl0" xml:lang="en-US">Security Exchange Name</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl0" xml:lang="en-US">Local Phone Number</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl0" xml:lang="en-US">Entity Central Index Key</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl0"/>
  </labelLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>igc-20230505_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Fri May 05 21:45:25 UTC 2023 -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <roleRef xlink:type="simple" xlink:href="igc-20230505.xsd#DocumentAndEntityInformation" roleURI="http://www.igcinc.us/role/DocumentAndEntityInformation"/>
  <presentationLink xlink:type="extended" xlink:role="http://www.igcinc.us/role/DocumentAndEntityInformation">
    <loc xlink:type="locator" xlink:label="DocumentAndEntityInformationAbstract" xlink:href="igc-20230505.xsd#igc_DocumentAndEntityInformationAbstract"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentInformationTable" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationTable"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentInformationLineItems" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DocumentAndEntityInformationAbstract" xlink:to="dei_DocumentInformationTable" order="1.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationTable" xlink:to="dei_DocumentInformationLineItems" order="1.0"/>
    <loc xlink:type="locator" xlink:label="dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityRegistrantName" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_TradingSymbol" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentType" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AmendmentFlag" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCentralIndexKey" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityEmergingGrowthCompany" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityIncorporationStateCountryCode" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFileNumber" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<!-- [WMV5][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt9uvRsJTXMeMewLyH9HKj6I6pbvcDxjLALOm5tfIsNSqwD4AozZ/F944Y87fOfI0y6vZTP3tzgy2QXberVkb2oH+mmiyBqSMiSzdFMawzswpAn9xLJSwxpmGh9i+JNdjlAkvKqUU101Y7MQNvtMJUnM3BNJMP4bvQrHrb3xpsYrtCHHkDpsrsMRceCOvoseKwSEhUCy2G1hKuvOqmlCf+c3] CSR-->
    <loc xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityTaxIdentificationNumber" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressAddressLine1" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressCityOrTown" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressStateOrProvince" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressPostalZipCode" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CityAreaCode" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_LocalPhoneNumber" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityInformationFormerLegalOrRegisteredName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInformationFormerLegalOrRegisteredName"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityInformationFormerLegalOrRegisteredName" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_WrittenCommunications" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_WrittenCommunications" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_SolicitingMaterial" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SolicitingMaterial" order="18.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_PreCommencementTenderOffer" order="19.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_PreCommencementIssuerTenderOffer" order="20.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_Security12bTitle" order="21.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SecurityExchangeName" order="22.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>igc-logo1.jpg
<TEXT>
begin 644 igc-logo1.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X1#@17AI9@  34T *@    @ ! $[  (
M   '   (2H=I  0    !   (4IR=  $    .   0RNH<  <   @,    /@
M   <Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                                 $%N9')E80
M  60 P "    %   $*"0!  "    %   $+22D0 "     S4Q  "2D@ "
M S4Q  #J'  '   (#   ")0     '.H    (
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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MW\:CH **** "O!OCCIC6WBZUU +^[O+8+G_:0X/Z$5[S7+_$'PF/%WA:6TB
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MV\DFGWDC3*ZKG='(NUMOJ5.>/\:])U?X]^"--CM6M;R74O.<!Q;1,#"O=FW
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%BB@#_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139951919098192">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document And Entity Information<br></strong></div></th>
<th class="th"><div>May 05, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information Line Items</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">IGC PHARMA, INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">IGC<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001326205<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">May  05,  2023<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">MD<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-32830<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">20-2760393<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">10024 Falls Road<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Potomac<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">MD<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">20859<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(301)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">983-0998<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationFormerLegalOrRegisteredName', window );">Entity Information, Former Legal or Registered Name</a></td>
<td class="text">India Globalization Capital, Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $.0001 par value<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSEAMER<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInformationFormerLegalOrRegisteredName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Former Legal or Registered Name of an entity</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInformationFormerLegalOrRegisteredName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>igcpharma20230505_8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="igc-20230505.xsd" xlink:type="simple"/>
    <context id="c0">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326205</identifier>
        </entity>
        <period>
            <startDate>2023-05-05</startDate>
            <endDate>2023-05-05</endDate>
        </period>
    </context>
    <dei:DocumentType contextRef="c0">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="c0">2023-05-05</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="c0">IGC PHARMA, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="c0">MD</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="c0">001-32830</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="c0">20-2760393</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="c0">10024 Falls Road</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="c0">Potomac</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="c0">MD</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="c0">20859</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="c0">(301)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="c0">983-0998</dei:LocalPhoneNumber>
    <dei:EntityInformationFormerLegalOrRegisteredName contextRef="c0">India Globalization Capital, Inc.</dei:EntityInformationFormerLegalOrRegisteredName>
    <dei:WrittenCommunications contextRef="c0">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="c0">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="c0">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="c0">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="c0">Common Stock, $.0001 par value</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c0">IGC</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c0">NYSEAMER</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="c0">false</dei:EntityEmergingGrowthCompany>
    <dei:AmendmentFlag contextRef="c0">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="c0">0001326205</dei:EntityCentralIndexKey>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>10
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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MIR1-\SR. !9GD*88 J<11S &P %#TG1X#SY['R73>RHY_U=3_ 102P,$%
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MR3J)T]UY<:*X+XGVZLN[D K=,+?S+$M5 ]ZD*VHAR*2FZ U+&W=9:B,8FQH
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M8U!R;W!S+V-O<F4N>&UL4$L! A0#%     @ <I*E5IE<G",0!@  G"<  !,
M             ( !S0$  'AL+W1H96UE+W1H96UE,2YX;6Q02P$"% ,4
M" !RDJ56SYS&:7X$  !A$0  &               @($."   >&PO=V]R:W-H
M965T<R]S:&5E=#$N>&UL4$L! A0#%     @ <I*E5I^@&_"Q @  X@P   T
M             ( !P@P  'AL+W-T>6QE<RYX;6Q02P$"% ,4    " !RDJ56
MEXJ[',     3 @  "P              @ &>#P  7W)E;',O+G)E;'-02P$"
M% ,4    " !RDJ56.JJBYT !   \ @  #P              @ &'$   >&PO
M=V]R:V)O;VLN>&UL4$L! A0#%     @ <I*E5B0>FZ*M    ^ $  !H
M         ( !]!$  'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QS4$L! A0#
M%     @ <I*E5F60>9(9 0  SP,  !,              ( !V1(  %M#;VYT
D96YT7U1Y<&5S72YX;6Q02P4&      D "0 ^ @  (Q0

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="igcpharma20230505_8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000 - Document - Document And Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.igcinc.us/role/DocumentAndEntityInformation</Role>
      <ShortName>Document And Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="igcpharma20230505_8k.htm">igcpharma20230505_8k.htm</File>
    <File>ex_514800.htm</File>
    <File>igc-20230505.xsd</File>
    <File>igc-20230505_def.xml</File>
    <File>igc-20230505_lab.xml</File>
    <File>igc-20230505_pre.xml</File>
  </InputFiles>
  <SupplementalFiles>
    <File>igc-logo1.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>15
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "igcpharma20230505_8k.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2023": 23
   },
   "contextCount": 1,
   "dts": {
    "definitionLink": {
     "local": [
      "igc-20230505_def.xml"
     ]
    },
    "inline": {
     "local": [
      "igcpharma20230505_8k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "igc-20230505_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "igc-20230505_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "igc-20230505.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd",
      "https://xbrl.sec.gov/sic/2023/sic-2023.xsd"
     ]
    }
   },
   "elementCount": 26,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2023": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 23,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "igc",
   "nsuri": "http://www.igcinc.us/20230505",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "div",
       "body",
       "html"
      ],
      "baseRef": "igcpharma20230505_8k.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:EntityRegistrantName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "000 - Document - Document And Entity Information",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://www.igcinc.us/role/DocumentAndEntityInformation",
     "shortName": "Document And Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "div",
       "body",
       "html"
      ],
      "baseRef": "igcpharma20230505_8k.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:EntityRegistrantName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.igcinc.us/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.igcinc.us/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_DocumentInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "localname": "DocumentInformationLineItems",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.igcinc.us/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_DocumentInformationTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package."
       }
      }
     },
     "localname": "DocumentInformationTable",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.igcinc.us/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.igcinc.us/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.igcinc.us/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.igcinc.us/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.igcinc.us/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.igcinc.us/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.igcinc.us/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.igcinc.us/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.igcinc.us/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.igcinc.us/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.igcinc.us/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInformationFormerLegalOrRegisteredName": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Former Legal or Registered Name of an entity",
        "label": "Entity Information, Former Legal or Registered Name",
        "terseLabel": "Entity Information, Former Legal or Registered Name"
       }
      }
     },
     "localname": "EntityInformationFormerLegalOrRegisteredName",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.igcinc.us/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.igcinc.us/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.igcinc.us/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.igcinc.us/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer",
        "terseLabel": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.igcinc.us/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer",
        "terseLabel": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.igcinc.us/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.igcinc.us/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.igcinc.us/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.igcinc.us/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.igcinc.us/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.igcinc.us/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "igc_DocumentAndEntityInformationAbstract": {
     "auth_ref": [],
     "localname": "DocumentAndEntityInformationAbstract",
     "nsuri": "http://www.igcinc.us/20230505",
     "xbrltype": "stringItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>16
<FILENAME>0001185185-23-000448-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001185185-23-000448-xbrl.zip
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M?"7^S!)GFH#*E)7BM9*+Z-] 67WV>O&EPKO'*8=N+FZ"B[;"9"AB^' );/D
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M@$%[):G9P[F?NPD8)91YQQE/"CTK4V>T-R7F4,81)U\G13S(AP=[_R*=.B@
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MN. ?HS); D.?-?/\Z?\'4$L#!!0    ( '*2I5:/O"[E-P0  +L,   0
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M/O_]))+KP6JLW_Y*\?\!4$L#!!0    ( '*2I5:%*\,)%08  ,,K   4
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M!05F=.;,V5/: -$VJ4F@K;]^DUY<*A>%=AW[22SAR9/G>9.\>=.#+YYM23-
M*,3HL%#:+18D@ QL0C0^+ QZ<K.GMEJ%+T>2].G@#UF6S@ "1&? E(:^I&+;
MZ1E0ZA,=T1$FMO07L_^69&G"F--0%-=U=PW>AAJ0 (JGQ !4/)!DF0/&D"H!
M K AG1(H:;HO%:M2N=38JS;*56G05Z5RL5P)?_+IP(+H8:A3(''>B!X6YGKR
MAL3:Q62LE(O%BA(W+(0M&YYXD&CO5H+6I7J]K@3?/C>E<%E##EM2;K5VSY@
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M0=4A?']5>?D":_#V\?/;N^*_?P%02P,$%     @ <I*E5@[!GE('$@  ?BP
M  T   !I9V,M;&]G;S$N:G!G[5<).)1?WWZ&&8.4%)$]VY1M;&.9/T:$(H1D
M"V%D-]:,O90664(H%2*D8HBQ12J,_@K9-649^Q)F,$QHO*/_]EWO]W[7MU[?
M]UW7ZWZ><SV_<\[O.?>YSSG7,_=L#VZ/ ON-#$X9 " 0"+C N(!MTOY1?:SG
M10 P,0&D 0!@!<"@7P F1@1E5(QN> )@1@QBQ!8/'^T\@7T L+]M3O!G/P>C
MKLTH@.#<SW=WL8M=[&(7N]C%/RF.^Z$#W9P9 >0.\T\GP<UP#+EWP'_&E:DI
M/V-FA"( I*;^%?_E*ECO[HRTZRIVL8M=[&(7N_CGAI*"DC)2 <&X1165D2HJ
M2(3Z/VQC^ _ #T #@8 ;L&-"MDE[#GL$!_LCX7"_('EG-,;%3=X5XPO'.OO#
M%>45X( F"NOO[.KM%BSJXN;NZ:<%6WK5"!/U1&O!K!$F"B;^>FX>GB?# ]TL
MPTW/NH9[NVJ@82CMO>R:6"36U]_7+=A9%.OKXQ>$Q&J)_1P=R8AWFN%BVIJ!
MZ(M(BQ,&OV<P:EIBO\\E-#14/E19'A/H#E?4T-" *RC!E93D&!ER06%^P<Y8
M.;\@\=\'..$6Y!KHZ1_LB?$3W:D[NV!"@K7$0D(\T<B+SA<1+F@T0L[%61DM
MIZB(=I9S1BLKRJ&5E=%J"$5UI8N*+F*_TZ-=_V3W#PGT^<F-=H6[^;CYNOD%
M!S%60Q$N!O^?Y60LT9^D_W#Y&1H9.4@]AF,,=CO!*-H[FRJG@&#<9__85'F$
M@IHF_._R-.%_-]'_@]72UD2[(EUWYH0)_(W>TBW@O[?;/I[:OQGHW_0QJK\%
MC($9IXZ-C4T3_B\Y__4BP'\_=(SHSR/*>%/T?P&[)+LDNR2[)+LDNR2[)/^_
M2/ZRN6Y^#&\;RC"QVU\ /0 *@;! P% 6" LK%,K*SK6'X3'8>3CW<W#Q\? ?
MYN/AXQ40AAT1$)(4XN43DQ>3/'I,1E:&7Q2N#)=6@DG+2.\, H*RLK*SL7/O
MV<,M+<@G*/V?QO8;@(N58=ISF$%B !,7B)D+M-T,B   " +ZB3_^!8"8F,$0
M%B@K&_L>1@)^/\ $8F9F C-#(& PHS>*T0^ N2 'CB@>9SEH[@P5"^!6NI+R
MF%5<M_PMCT4764+9)3"6C?T0+]]A?DDIV-%CTBH(535U#:3>"7T#PY.GC"S/
M6IVSMK&U<T6[773W\/0*"@ZY%(H-"[]Z+>[ZC9NWXE/3[J9G9-Z[GY67_Z2@
ML.AI\;.7%97XJNJ:VKIW3<TMA-;WO[9U]_3V]0\,?B:2QL8G)J>F9V;G*,LK
MJ]2U==KWC1U=(( 9] ?^H2XNABXF,)@9#-W1!6(*W4G@ D..*+(<.&X.=0XX
M**9TA95;-^5Q^5LV<64+,H]+8!?[(0D5DB1E1]I/9?\Q8;'_)65_"OM+%Q'@
M8 8Q-H^9"T !&\>3NDQ6M(J=%ND((0#U<2W_XUJAN0[GBM931FNZM65O27"4
M_/B9QCN&&+^XH88&:.VLSCBO5%XU>CUTK?\0+BA*Y1+90&G9B&05<] JV&F_
MY_"1,K4LK7=?O]SBB'@C/B6$1:Q@$K8"GM):S>'^[7OO^F[>UD=)<UK.#5-G
M1D!V04_FV3\O@REW5X<J%W^H]G.5M&M;E:_:/$PG^9LVG(H@>O8X]5([E8G)
MRL3[^GZ1H]O S[@"7^+5U$34(A0__UJ"+ZA;#!-8!4)A9;B'D6:4]>9AT=[$
MS&LE]+>^XM_B+%!*8TZG-P[.0$)(Y/0 $98/Q?*G1$Z_?NPK^($[C?!2\8WN
MN,0/:8PRL?X5Z<:5D"\*6=M TE)1;>_7BWM@F-1!D;$+ZO"MU_C9OD0;@P.3
MMVOZ\[<ZO30[O=QX[K1^S^X-R^YM.PJBN^/5!1-ZK:2CNG18MX%0RM,YP\W&
M1$,="+>Y#@2[#;2:A'7)JO Y[1'=/#TJG"MX%%6,NX![I*W8UAUYLNZ<IB'8
MJ-&DEH[N1PSE1GR&\/42BN O'_Q 6=ZNJ,RBKPD86XVH='#Q]F9M9+YS%*@F
MXZXOK'[ W+^+R3)=/AF>LS)H?3WR:)D]CC>J\'@ZWJ0)->R:/)FUH3@HIJRF
M#\[)?4&F=$_G-]^[KT&(_1(Z)\<31^H4P(:V7"%<?:87(A$3+;B0$OTL;,N3
M.)VPI48JUFP(M:MXF>E'XDZ-I%&)&BVA$1HK@;8CY91U UAS#'3&4;+B^DK+
M1DM[1DI1[!*[43FA_<>4^J_JH^R4"HKU6SK[HW&:-^FHH]7WF$K<8&9,KH9/
MM/BL@U.S&5>D"NW&WH:&Z41YG\1:*924FD)JQ,OTM]K4MED12+W<BRH?;3&[
MKT5/S@!-9+F6"*Q'3YR,R_D28CN\*4CMTNJQ'*(RP5?JM)V'V>(+<'0MHJ2(
MWF7=H3N742$NK&;O>\%L\PGGM(/\@TT-FIF_&I)*G5DLK_?,><^_5*]!;GQ+
M/Y1RL;O2P^3=:DV-E"VT1JZ'W&+B]3W\7((\?=3(+0?BC2QL>!+5:/$RJ_NP
MP@5>Q6OIK>OQ25=[- <,C4\Y2F0%UIU#L!_->\)48%8G+9VN/9,+CGE%ZPT1
M_S%"R,]EBC^:RU0O,)YTKW]8'M_+1%]<'I2/(>I=W>!R7#G?V"S"ELR+M;,_
M>9GW3HYJ7_+ZF\U&7?6MY\CRJ<1DZV,MAGMN)TQ6=&UU2M,,X](L ]9O9";W
M-RS";)T-!9\_1:P,-+$Y-C57;X1TJUAJVBC6O.6XD4*=:NC1JUWQY9"-]D@6
M,>JXNNX3'GG<I*[#^\-B.:7SUC<J)WA+OS<7GV5O_%RFU4,J,;[,(E2&>9$5
M9T;>!N+K-2BQ!#GF,4$VW]+F5[X(&\ @;<.]5Y@3?\F)G\Z+2I#EM?\T!K6M
M2/9N1DW.*7:,K-_ .&:G+Y.5;8?0F%BLTY MG\BGJT[>!F<(71:F/0[A1?33
MWZ'8BJYZ9[):BS:_>TU/'IW8TRJ#R)O201%-&S/TPUJ72OQ0DT\.'ED_9[G5
M$G6$_'SL85UAEAS._F-M-6!RR/\D?6,;,)]WS'R*#7I'5\(?F+.SRLXM:;U'
MV3N_4!.X-RC&H^^QO!&E,4M$+#Q_HEUDS/#F:N+SM<:J$XW+'1-^6P^>;LU_
M"C9+*A>U:C3^(+78A<K*29G^/I!_?@L@\S3'=;<M?A4AQ2^4;TR5SL: (R$%
M;2_E$]>*+._X37E"?RR;HHS:2I69S1W>CFRL\"?<60)'ZCH=ZA#O67?2;9R7
MVO^2E?XD(5K(N_[I0DEN1;5QA+IX+#>?S9C.LT8=:2.*M)%2^NB+Q/WF^CSW
MWOW;9X51]ADWOP97]X5X(-J/]7?:5%\('9]X&$P<C0C(JG#G&<Z).FC"++^4
M?GDB:%'F25Y1NN/,@@TQN]TRN]A#+FP;2([FI,6T2BZV/?K%2IR.$C5?R5D;
MR(\*WQR(T?<U?3%KG+7O(\E3JS,MQ"S.49,6\ZRPH,A.@#;J4]*>A :'<N1@
MF;^Z- B\V0;VY_6R*J ^(\!C8P3,W9SSS+W1>0U53X=GLLX](5'WJG9/#BS6
ME\DH;!Q0DGE=^,L70I\K+M@HL4JHT.O,7(8+%JLEQ&FEG>Z76UF.+T\H>,C&
MGOW8T"Z[?L![QL9<G_ORT;QX0/KL9EY>L>5B/+#SB53*<+UIDZRW]7QZZ8JC
M;*-GI'7$F-"YY64BX;.[V-BEM N06P0S0?:9@N.]1<>*R%\H!R]=TKY,"#=/
M",'=#YZ-#*,TVC;65?<+&':5V"_>LA6[*:Q+"KO8*I'378>Y,2Q$,;N^%096
MQBX2-O4)#A!R9B?L"C^A5?KS(LIN+ANB"\_ROA^\#<2:(3J#\Z'=]2)C-Y+J
MC4LCCR>_T69YM(#F$,_V<')]/X%.W ;>/4..#^=6T8PI:DWAC]*GXL;PM>F3
M3.,A3=\20F5+[LQO]+[@/V-1C#A$/97\P($S.J\^;4PJ?RQ,6XKFU&2G=K.P
MFZ7 :SBRBG+=8AREVK-*?;:&G+X=>9#B;DA^73N&H$AFE!9EWI0H$_;'SK[?
M,O!&7/-C-S):<"1^>WUNG^O@#$ZIBF*0EU-I\#C/P<LGZT2X5UM&M](UZR-A
MTXU2#RBN+:%$D_5KXV1ZR<3M!G.76ALA^X^ZUE<'DDR,WK5W*"SB:.<U*K6T
MXXM>S%41A1/#GCFI?HE0M[/E+!-"":>/C[#31;&I*X3;KN/''GZAQ7[&!1=$
M@O@X1L0HGRYCM:_V%V8+AQQK\T:K?OL6X<LS/2* &+)LRMGGN WH-:2VS3@T
MQ]I0'A5I" X(C-5JAI(WFU3I,&%M>I])5V;YJRK] RRMS.#IU9)CS@XV11_3
MAS*V@0F8C/"T?IAA2P[W? 8=3.YC?%HDNQ>I]C7F\:ZBIP[_8FIX>GRY!!='
M5\JTI<7(==XL0A'Y-5._S,%A>^\MAXH\H^?VUJOTP;VG+TSUMT;H8WF;.H5H
MN&:10]]0E=3#A)1GK4%!ON@ O(O NTN=$._>UY+8%[1?WH02[\K1[\V)5CA.
MN9/\M>KHW'/.,-,7GGZ#QZ1*0T(8O^2.MN2(%KN^%2\Z/^7NDGQMP7L).7DU
M35,69,C;UA^K,KT]B_$$/,S(C\-SB"/GAW$4YS+N7C3;K(5W'2:ILF:?Y*LR
MKB.H84G*QD"O[*M,:$$079 ,OQ$IB?CX6K@GM<TX%_RQM/T55'SI8!*^@4.W
MP"A@;@&3=M#:/392B-*11A)"V9-S$K)-%,X;C;SV^'6P116I"A(E*Q)D,BMZ
M--4*(MW(D]57J:<0]J H'Y/FXLJE%1:=T8A+N((M8W+KNVBYNLUSU4]:)?L5
M_,2D- 3FSJ[0>J-%:.:C(QS#DL.9^2?D\S5.3;O*'*$*)('6>69DH[@G51Y-
MX.WLMH'[FCC7EGKC4'@3BJBU=;SXRZ]2.6'BITN?/^IZ_\H>4VR9C2(TP*QI
MZZ.)JK^<P]=G6JP\A![J4E# 7?)]$ZV7M4A=XO"@PWKH+;A!O2B6P.?2RT5]
M)R=$"H*0UF\Q3#,;L</V'L]ENZHF-D\DBCVFLINBD-/8!(1-2[_9?1G/"J&L
M05*TI&>_(YS6-'K[E-LC'_P>F+.$K&N:YP<FSC/AUF$D3)PP+SFCY$>Q,Z2E
MA6;Q/"!,(_V.\+ZOJ^,) Y8!N;.9X25514&N&#EJKM@P:1PR!GUJ2<2%15,[
M+7E@IBJCQ%.V/\8G^Z>O>@MS=]>[;AI[A?N]$DRUE\]*C4O2O>%OU2H^?U9;
M? M)7H]%Y+":D6BP>.,2VP-ZL@M2.F[B.%/\TJE<SX!YLQ>2B75S%H:3#8,)
M80F-0W(#W%YV+)DO$!5>5:KKB=ZP!Z LA6'+;2 LZ!-9QF.\X+"A=5MZR3+O
ML<E&(;SQD(D*#C0C,S6'_/@:G;+8NCB0"RN3<*<SGX])6EVZF9%EFE+JA61)
M+VHBN22"JPYFA.B<O1!K:GTEA_#Z"H;3TZQ4_N5&5(675[;=,-_;._**EX<"
M8KWZ^A)X^U.)PR?2OGPLD(C7;ZO+SDT:2Y=U*> S4*RS'^F,:=()J!W?!@Y3
M'V"X(J&5?=^2G.NSB5;; /KA1-3Q]ULR=R@B5U3, %IU$S^AV%<UGQ3QZ59@
MIE+%CVP7T-<H0XW6<IZE$A(GY^OK=<HS:[Z%XDOVRJS+?14/XV9[^TH,=7M"
MHM0V45;EU?45WV,"5)S3DAZ*& 67Q]\]*Q[A,-)%?RJ(*9Y""9UVUR,_OER<
M,._/?:S'KR<APJ6F\=8GK^%#E#5\GL?)Z/9Q[!@[5  ]S#P^WQ&5U; VW81$
M+"06/)IZX*V%3Y.QUY<XGG$@G_WLI3?%I:L.2/I:__):QY[;#U3AOBHIUSUL
MJ-(1%OD)B9(\W@4Q'?,4G?&@]^/=HI]0'BCHK&H^ERTVZO'Y?34')N@P&.49
MZD I-8<_TJ:,O![GLT#EI!D"#377QTS*56JA'%'7NY*#''NDX@H_O&AY_L&-
M>4Z!X)(T0]!LUGOX%&-J-FU23EY++W0:<IS=B,+C^\;]:K+5WX29!F5H?5?)
MOVUDY.M0@,F):=8(%V8K<<*VOA/A5DD6PC89E?>,UH:4U:D>R+36199)+$-1
M9/X->2GK6PY\2F5M99I<\V?Q#IRF [(FV15N$&KY!8+ S:920[VKYQ9&D_J)
MZG)=KO&2K#?S03JC()L!'']74H:WF4PP_SF)O'B9N[EY\4>!?Z<P;W_^&U!+
M P04    " !RDJ56GAY4);(7  #'A   &    &EG8W!H87)M83(P,C,P-3 U
M7SAK+FAT;>T]^7?;-M(_-W\%/G>W*W=U4)*56++C?8IL)VKBHY;2)KMOWSZ(
MA"0D%*D"I([\]=_, *2HPU?KQ$[B'K9%7#.#N3&@]O\U&_EL(I268?!\JUQT
MMI@(W-"3P>#Y5K/3:K>W_G7P9/__"@7V4@1"\4AXK#=GK7 T[KB2=14/=#]4
M(Y:+1MNLP(91-&Z42M/IM.A"'^U*)708*U=H?, *!3M=2PF<K,&.E60G?,Z<
M&JN4&SNU1J7&WG9;K.)4JJ;[, (@ =! -^3 ?;Z560,^R\ MQKJ$W9V:4]M*
M>LZBI9ZSGO*+H1J49.#+0+Q[<?&F%"70\PCPQRF<@E,IE"N920I:+"\)GXN#
M<'+E/.5:P=DM5,O)/-#SXV9H*HY3+6%SCVN1=/>$3'M3SV1-:"!$4_ATN%,I
M/[MB:MLC&8"-\JKN@8YXX*:0V#U,1VS:TP6Q+INX7,U0*P5%+P,RK29@E$OO
M3MYTW*$8\<(J0+$N1/.QT.G0/M<]&IBT+!%HYE^![+LW0/<L9;P5LMN>3TNF
M,0/#@//Q1A"P81D"_2>PG*TQC!U7KM?K)6JU72_OA%*S=; _%-P[>/+#?B0C
M7QR O(R''!@U$9?_[7XL0L_]DFE_ CW7A+T[C -/J,-P)-AYJ"+N@Z#72C7"
MD]4;Y5JC6F7G)R2M3_9'(N+,#8-(!"""D9A%)8*%=$-!_!'+R?.MEFDO=&'+
MME@)I+QD(-WOA=[\8-^3$Z:CN2^>;_6A:T'+3Z+!RLXXVF/TH,]'TI\WV$\_
M5G?VNG(D-#L54W81CGA S_;8F'NHR!K,D0%SBF49[#$W5CI4#<;C*-S;HG5P
M;?RU/U3)DD,A!\.HP:KC&0P)?1SQHT/_[+$>=S\.5 @T*:PV3:47#1%,Y^_0
M+U1 M08+PD#LL1%7 QG@E!%SMDK7K5R^^Y4=^'?CZN,E2M^ L-D=>9KNR(0K
MR8,(EP4&\_<8;GV!^W( B[NPV4)E@(%A0/[>P=O3=O?HD'6ZS>Y19[_4.]@O
MC2UX#P*^SE'K[46[VS[JL.;I(3MZUWK5/'UYQ%IG)R?M3J=]=GH+H%? W5L
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MZ1Z%8SMGM5CY.PWX8B)Y4QV*>:J&CD CCE4X07985IY&&-H!\/G8LGH'>[?
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M_;ZE0YC;9J??-#O=PB(=O)9O/NY>K#P;]@LJG*X_Q#P3,PGJ37G;)YNRN%F
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M>%\U,30X,# N:'1M4$L! A0#%     @ <I*E5H^\+N4W!   NPP  !
M         ( ! SD  &EG8RTR,#(S,#4P-2YX<V102P$"% ,4    " !RDJ56
MA2O#"14&  ##*P  %               @ %H/0  :6=C+3(P,C,P-3 U7V1E
M9BYX;6Q02P$"% ,4    " !RDJ56<W.\K!T(  "44P  %
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2      < !P#  0  &'P

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
